| Literature DB >> 24278503 |
Hwan-Goo Kang1, Sang-Hee Jeong, Joon-Hyoung Cho.
Abstract
The present study was conducted to investigate the antimutagenic potential of the methanolic extract from the leaves of sweet potato (Ipomea batatas, IB) with the SOS chromotest (umu test) and Salmonella typhimurium TA 98 and TA 100. The anticarcinogenic effects were also studied by calculation of the IC50 on human cancer cell lines and investigating the function of gap junction in rat liver epithelial cells. The IB extract inhibited dose-dependently the β-galactosidase activity induced spontaneously at concentration of more than 200 mg/ml in S. typhimurium TA 1535/pSK 1002, and decreased significantly (p < 0.01) the β-galactosidase activities induced by mutagen 6-chloro-9-[3- (2-chloroethylamino) proylamino]-2-methoxyacridine dihydrochloride (ICR) at dose of more than 0.4 mg/0.1 ml. The IB extract showed no effect on the spontaneous reversions of S. typhimurium TA 98 and 100 but benzo (α) pyrene (BaP) -stimulated reversions were decreased dose-dependently (p < 0.01) at the concentration of more than 100 mg/ml. The IC50 value of stomach cancer cells was lower than that of normal rat liver epithelial cells, but the values of colon and uterine cancer cell lines were similar to those of normal rat liver epithelial cells. The transfer of dye through gap junctions was not affected by treatment of the IB extracts at any concentration during treatment periods. The simultaneously treatment of IB extract and 12-O-tetradecanoylphorbol-13-acetate (TPA) effectively prevented the inhibition of dye transfer induced by TPA 1 hour after treatment at all exposed concentrations. The number of gap junctions was significantly (p < 0.01) increased by the treatment with IB extract at concentrations of more than 40 μg/ml. The inhibition of the expression of gap junction proteins by TPA (0.01 μg/ml) was recovered dose dependently by the simultaneous treatment of IB extracts. Our data suggest that Ipomea batatas has antimutagenic and anticarcionogenic activity in vitro.Entities:
Keywords: Anticarcimogenicity; Antimutagenicity; Gap junctio; Ipomea batatas; SOS chromotest (umu test); Salmonella typhmurium TA 98/100
Year: 2010 PMID: 24278503 PMCID: PMC3834463 DOI: 10.5487/TR.2010.26.1.029
Source DB: PubMed Journal: Toxicol Res ISSN: 1976-8257
Inhibitory effect of IB extract on the expression of SOS gene (umu C'-'lac Z fusion gene) induced spontaneously and by ICR in S. typhimurium TA1535/pSK1002
| Treatment |
Dose (mg/m | Activity of β-galactosidaseaa | Inhibitionb ratio |
|---|---|---|---|
|
| |||
| Control | 0 | 118.4 ± 1.3 | 1.00 |
| IB | 0.8 | 113.8 ± 1.3 | 0.96 |
| 4 | 113.6 ± 0.8 | 0.96 | |
| 20 | 107.0 ± 0.5* | 0.90 | |
| 100 | 93.9 ± 2.1** | 0.79 | |
| 500 | 92.5 ± 2.3** | 0.78 | |
| ICR | 0.3 | **346.3 ± 5.0 | 1.00 |
| ICR | 0.3 + 0.8 | 334.5 ± 8.9 | 0.97 |
| + | 0.3 + 4 | 322.0 ± 2.7** | 0.91 |
| IB | 0.3 + 20 | 258.6 ± 2.9** | 0.67 |
| 0.3 + 100 | 178.1 ± 2.6** | 0.37 | |
| 0.3 + 500 | 122.5 ± 1.6** | 0.13 | |
IB: Ipomea batatas.
ICR: 2-methoxy-6-chloro-9- (3- (2-chlorethyl) aminopropylamino) acridineㆍ 2HCl.
a: Activities of β-galactosidase were presented in unit and the values are mean ± SE of 6 replica from which basal levels were not subtracted.
b: The ratios are defined as the value of the β-galactosidase unit of IB divided by that of control in the case of IB and as (M1-M2) /M3 where M1 is that of ICR + IB, M2 is that of IB alone and M3 is that of ICR alone from which that of control was subtracted in the case of ICR + IB.
* or **: Significantly different from control (in the case of IB and ICR) or ICR (in the case of ICR + IB) at p < 0.05 and p < 0.01, respectively.
Inhibitory effect of IB extract on the reversion frequency induced spontaneously and by BaP in S. typhimurium TA98 and TA100
| Treatment | Dosea | TA98 | TA100 | ||
|---|---|---|---|---|---|
|
| |||||
| Revertantb | Ratioc | Revertantb | Ratioc | ||
|
| |||||
| IB | 0.08 | 51.4 ± 4.0 | 1.09 | 147.6 ± 5.20 | 0.97 |
| 0.4 | 46.1 ± 2.1 | 0.98 | 144.6 ± 7.4 | 0.95 | |
| 2 | 50.6 ± 3.1 | 1.07 | 143.1 ± 7.5 | 0.94 | |
| 10 | 46.6 ± 2.0 | 0.99 | 159.3 ± 5.4 | 1.05 | |
| 50 | 40.8 ± 2.8 | 0.86 | BK | - | |
| BaP | 2 | **314.6 ± 15.3 | 1.00 | **604.4 ± 46.7 | 1.00 |
| BaP | 2 + 0.08 | 313.8 ± 16.2 | 0.98 | 604.8 ± 51.6 | 1.01 |
| + | 2 + 0.4 | 337.8 ± 9.2 | 1.09 | 558.8 ± 56.6 | 0.92 |
| IB | 2 + 2 | 341.2 ± 8.7 | 1.09 | 599.6 ± 44.7 | 1.01 |
| 2 + 10 | 231.8 ± 16.9** | 0.69 | 665.5 ± 43.8 | 1.12 | |
| 2 + 50 | 51.1 ± 3.1** | 0.04 | BK | - | |
BaP: Benzo (a) pyrene.
a: Units of doses of IB and BaP are mg/plate and μg/plate, respectively.
b: Revertants are the number of revertants/plate and the values of mean ± SE of 9 replica from which the number of spontaneous revertants were not subtracted.
c: The ratios are defined as the number of the revertant of IB divided by that of control in the case of IB alone and as (M1-M2) /M3 where M1 is the number of revertants of BaP IB, M2 is that of IB alone and M3 is that of BaP alone from which the that of control was subtracted in the case of BaP IB.
BK: Bacterial killing effect.
**: Significantly different from control (in the case of BaP) or BaP (in the case of BaP + IB) at p ≺ 0.01.
Inhibitory effects of IB extract on the growth of normal rat liver epithelial cells and human cancer line cells
| Cell type |
IC50 (CI) μg/m |
|---|---|
|
| |
| Rat liver epithelial cell (WB-F344) | 1,035 (105~10,224) |
| Stomach cancer cell (SNU-1) | 244 (193~309) |
| Colon cancer cell (SNU-C-1) | 854 (715~1,019) |
| Uterus cancer cell (ATCC-CCL-2) | 950 (854~1,056) |
| Liver cancer cell (ATCC-HB-8065) | 2,125 (1,331~3,393) |
| Lung cancer cell (ATCC-CCL-185) | 2,494 (199~31,329) |
IC50 is the concentration that shows 50% growth inhibition of cells in MTT assay.
CI: 95%confidence interval.
Effect of IB extract on the gap junctional permeability in WB-F344 rat liver epithelial cells treated with/without TPA
| Treatment |
Dose (μ/m | No. of dye-transferred cella | |||
|---|---|---|---|---|---|
|
| |||||
| 1 | 4 | 8 | 24 hrs | ||
|
| |||||
| Control | - | 183.2 ± 5.6 | 189.9 ± 3.5 | 200.8 ± 7.2 | 213.2 ± 7.9 |
| IB | 8 | 187.3 ± 6.1 | 188.7 ± 4.9 | 208.5 ± 6.8 | 211.2 ± 9.5 |
| 40 | 179.0 ± 1.9 | 203.0 ± 8.4 | 206.5 ± 3.4 | 217.8 ± 4.1 | |
| 200 | 190.0 ± 11.0 | 203.7 ± 3.2 | 183.5 ± 7.9 | 208.0 ± 6.1 | |
| 1,000 | 189.8 ± 6.8 | 190.5 ± 6.2 | 193.3 ± 5.0 | 218.0 ± 1.7 | |
| 5,000 | 177.7 ± 5.0 | 223.8 ± 6.3** | 208.3 ± 8.9 | 205.0 ± 6.2 | |
| TPA | 0.01 | **14.8 ± 1.6** | **16.5 ± 1.3 | **21.2 ± 2.2 | **72.0 ± 4.5 |
| TPA | 0.01 + 8 | 16.2 ± 1.0 | 60.5 ± 5.5** | 70.2 ± 7.7** | 133.3 ± 6.3** |
| + | 0.01 + 40 | 20.5 ± 2.8* | 90.0 ± 4.0** | 93.7 ± 10.4** | 166.0 ± 4.5** |
| IB | 0.01 + 200 | 31.0 ± 1.9** | 95.3 ± 5.2** | 97.6 ± 5.5** | 189.5 ± 5.3** |
| 0.01 + 1,000 | 27.2 ± 0.7** | 100.5 ± 6.7** | 107.2 ± 8.3** | 168.0 ± 3.2** | |
| 0.01 + 5,000 | 29.7 ± 1.0** | 110.8 ± 6.5** | 92.7 ± 5.2** | 178.2 ± 4.2** | |
TPA: 12-O-tetradecanoylphorbol-13-acetate.
a: The values presented are the mean ± SE of 12 (1 hour) or 9 (4, 8 and 24 hour) replica.
* or ** : Significantly different from control (in the case of IB and TPA) or TPA (in the case of TPA + IB) at p<0.05 and p < 0.01, respectively
Dye-transferred cells are examined under epifluorescence microscope (× 200 magnification) .
Effect of IB extract on the expression of gap junction protein in WB-F344 rat liver epithelial cells at 8 hour after the treatment with/without TPA
| Treatment |
Dose (μ/m | No. of gap junction/cella | Induction ratiob |
|---|---|---|---|
|
| |||
| Control | - | 10.8 ± 0.6 | 1.00 |
| IB | 8 | 11.4 ± 0.4 | 1.06 |
| 40 | 12.8 ± 1.0** | 1.19 | |
| 200 | 14.6 ± 0.5** | 1.35 | |
| 1,000 | 15.4 ± 0.5** | 1.43 | |
| 5,000 | 16.2 ± 0.3** | 1.50 | |
| TPA | 0.01 | **4.1 ± 0.2 | 0.38 |
| TPA | 0.01 + 8 | 5.3 ± 0.1 | 0.49 |
| + | 0.01 + 40 | 6.8 ± 0.1* | 0.63 |
| IB | 0.01 + 200 | 7.3 ± 0.6** | 0.68 |
| 0.01 + 1,000 | 9.6 ± 0.7** | 0.89 | |
| 0.01 + 5,000 | 11.0 ± 0.8** | 1.02 | |
a: The values presented are the mean ± SE of 6 replica.
b: The ratio is defined as the number of the gap junction proteins expressed per cell of IB, TPA and TPA + PJ divided by that of control.
* or **: Significantly different from control (in the case of IB and TPA) or TPA (in the case of TPA + IB) at p<0.05 or p<0.01, respectively.